Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Discover how a new AI tool can predict Alzheimer's with 80% accuracy, transforming early diagnosis and patient care.

"This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer ...

While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in diagnosis, treatment and risk management that have been made in 2024.

Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research led by scientists at the University of Bristol (UK) and the Federal University of São ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease, the road to a cure seems long and uncertain. But as the year comes to a close, experts are ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer's disease in 2025. Companies including Biogen Inc. and Eli ...

Jan. 15, 2025 — Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research has found. The findings provide new hope in the battle against this ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...

Housed on Long Island, it may well serve as a model for similar centers across the country as it will offer free, hourlong day programming in small groups. Those with Alzheimer’s will also be ...

A daily pill which could be the first to slow Alzheimer’s disease is being considered for use on the NHS. Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient ...